Develops next-generation targeted therapies for immune-mediated diseases using precision data analytics to improve patient outcomes.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Alumis is a biopharmaceutical company focused on transforming treatment for immune-mediated diseases by advancing a portfolio of next-generation targeted therapies. Leveraging a precision approach powered by proprietary data analytics, Alumis aims to optimize patient outcomes across a wide range of immune-related conditions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Alumis Management Team
Investors
Foresite Capital
Matrix Capital Management
Alumis Valuations & Financials
View real-time NPM data on Alumis stock including daily Alumis stock price estimates, valuation history, and historical share price information. Access Alumis financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Alumis pricing across six independent market signals. Looking for private company due diligence data sources on Alumis? Get in touch to learn more.
Similar Companies
like Alumis
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
CIONIC
Healthcare & Life Sciences
Augments muscle activation to restore mobility through smart wearable stimulation.
Trailblazer Technology
FinTech
Cloud-based insurance technology solutions designed specifically for small insurers, built by experienced industry veterans.
InsightFinder
AI & Machine Learning
Delivers predictive analytics and anomaly detection to prevent system failures and optimize performance.
Cognoa
Healthcare & Life Sciences
Provides AI-enabled screening and care tools for early developmental and behavioral challenges.
GigaIO
Enterprise Software
Enables infrastructure that composes computing resources on demand to support AI and high-performance workloads efficiently.
Halo Industries
Industrials
Develops proprietary laser-based tools and processing technologies to manufacture high-quality silicon carbide wafers.
C. Light Technologies
Healthcare & Life Sciences
Using AI-powered retinal eye tracking to translate eye movements into objective neurological health metrics for rapid, noninvasive assessment.
OpenEnvoy
AI & Machine Learning
Automate finance that reconciles invoices, applies cash, and audits spend using AI to reduce errors and accelerate cash flow.
FAQ
We have answers
Alumis stock does not trade on public stock exchanges. Alumis stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Alumis stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Alumis Stock does not trade on public stock exchanges. In order to sell Alumis shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Alumis does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Alumis share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Alumis stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Alumis stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Alumis stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Alumis is a private company and has not had an IPO. There is currently no Alumis IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Alumis IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
